GARLENCE Trademark

Trademark Overview


On Thursday, May 13, 2010, a trademark application was filed for GARLENCE with the United States Patent and Trademark Office. The USPTO has given the GARLENCE trademark a serial number of 85037900. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 27, 2017. This trademark is owned by Glaxo Group Limited. The GARLENCE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
garlence

General Information


Serial Number85037900
Word MarkGARLENCE
Filing DateThursday, May 13, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 27, 2017
Registration Number3934044
Registration DateTuesday, March 22, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 4, 2011

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 27, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events


Event DateEvent Description
Friday, October 27, 2017CANCELLED SEC. 8 (6-YR)
Tuesday, March 22, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 22, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, January 4, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 4, 2011PUBLISHED FOR OPPOSITION
Friday, November 26, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 9, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 6, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, November 6, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 6, 2010ASSIGNED TO LIE
Thursday, October 21, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, August 25, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, August 25, 2010LETTER OF SUSPENSION E-MAILED
Wednesday, August 25, 2010SUSPENSION LETTER WRITTEN
Tuesday, August 24, 2010ASSIGNED TO EXAMINER
Wednesday, May 19, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 17, 2010NEW APPLICATION ENTERED IN TRAM